Vito Amodio

6PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 03, 2026
Calreticulin exposure is a critical mediator of high-dose vitamin C-induced immune surveillance in the tumor microenvironment.

|Apr 21, 2026
Pharmacologic Inhibition of PMS2 Induces MMR Deficiency and Response to Immune Checkpoint Blockade.

|Sep 24, 2025
Mismatch Repair as a Dynamic and Clinically Actionable Vulnerability in Cancer.

Eleonora Piumatti, Pietro Paolo Vitiello, Vito Amodio

|Jun 02, 2021
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.

Vito Amodio, Gianluca Mauri, Nicole M Reilly

|Feb 28, 2020
High-dose vitamin C enhances cancer immunotherapy.

Alessandro Magrì, Giovanni Germano, Annalisa Lorenzato

|Nov 09, 2019
Adaptive mutability of colorectal cancers in response to targeted therapies.

Mariangela Russo, Giovanni Crisafulli, Alberto Sogari

Pageof 1

Frequent Collaborators

6 joint publications

Alberto Bardelli

5 joint publications

Giovanni Germano

3 joint publications

Federica Di Nicolantonio

2 joint publications

Pietro Paolo Vitiello